The Emerging Role of Major Regulatory RNAs in Cancer Control

The Emerging Role of Major Regulatory RNAs in Cancer Control

Blog Article

Alterations and personal variations of RNA interactions have been mechanistically coupled with disease etiology and phenotypical variations.RNA biomarkers, RNA mimics, and RNA antagonists have been developed for diagnostic, prognostic, and therapeutic uses.Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are two major types of RNA molecules with regulatory roles, deregulation of which has been implicated in the initiation and progression of many human malignancies.

Accumulating evidence indicated the clinical roles PLATINUM 100% GLUTAMINE of regulatory RNAs in cancer control, stimulating a surge in exploring the functionalities of regulatory RNAs for improved understanding on disease pathogenesis and management.In this review, we highlight the critical roles of lncRNAs and miRNAs played in tumorigenesis, scrutinize their potential functionalities as diagnostic/prognostic biomarkers and/or Computer Adaptor therapeutic targets in clinics, outline opportunities that ncRNAs may bring to complement current clinical practice for improved cancer management and identify challenges faced by translating frontier knowledge on non-coding RNAs (ncRNAs) to bedside clinics as well as possible solutions.